$Beneficient (BENF.US)$
Beneficient Reports to Kansas Legislative Committee on Its Positive Developments and the Digital Transformation of the Alternative Asset Industry
Beneficient (BENF) provided an update to Kansas Joint Committee on its operations and economic development activities under the TEFFI Act.
The company reported its second consecutive quarter of positive diluted EPS through September 30, 2024, and received board authorization for up to $5 billion in fiduciary financings.
A k...
Beneficient Reports to Kansas Legislative Committee on Its Positive Developments and the Digital Transformation of the Alternative Asset Industry
Beneficient (BENF) provided an update to Kansas Joint Committee on its operations and economic development activities under the TEFFI Act.
The company reported its second consecutive quarter of positive diluted EPS through September 30, 2024, and received board authorization for up to $5 billion in fiduciary financings.
A k...
1
$Zevra Therapeutics (ZVRA.US)$
Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C
Zevra Therapeutics (ZVRA) announces the commercial availability of MIPLYFFA™ (arimoclomol), the first FDA-approved treatment for Niemann-Pick disease type C (NPC). The medication is indicated for use with miglustat to treat neurological manifestations in patients 2 years and older. The company reports early adoption exceeding expectat...
Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C
Zevra Therapeutics (ZVRA) announces the commercial availability of MIPLYFFA™ (arimoclomol), the first FDA-approved treatment for Niemann-Pick disease type C (NPC). The medication is indicated for use with miglustat to treat neurological manifestations in patients 2 years and older. The company reports early adoption exceeding expectat...
3
$Connexa Sports Technologies (YYAI.US)$
CONNEXA HAS CLOSED THE ACQUISITION OF A FURTHER 50% OF YYEM AND CONFIRMS THAT TRADING OF THE POST-ACQUISITION YYAI WILL COMMENCE FRIDAY, NOVEMBER 22, 2024
CONNEXA HAS CLOSED THE ACQUISITION OF A FURTHER 50% OF YYEM AND CONFIRMS THAT TRADING OF THE POST-ACQUISITION YYAI WILL COMMENCE FRIDAY, NOVEMBER 22, 2024
$Phoenix Motor (PEV.US)$
Phoenix Motor Inc. Announces Receipt of Nasdaq Delisting Notice
Phoenix Motor (NASDAQ:PEV) received a delisting notice from Nasdaq due to non-compliance with listing rules after failing to timely file its Q3 2024 10-Q report. The company has until January 21, 2025 to submit a compliance plan. If accepted, Nasdaq may grant an extension until May 19, 2025 to regain compliance. The company's stock continues trading under PEV symbol while they work to complete and file ...
Phoenix Motor Inc. Announces Receipt of Nasdaq Delisting Notice
Phoenix Motor (NASDAQ:PEV) received a delisting notice from Nasdaq due to non-compliance with listing rules after failing to timely file its Q3 2024 10-Q report. The company has until January 21, 2025 to submit a compliance plan. If accepted, Nasdaq may grant an extension until May 19, 2025 to regain compliance. The company's stock continues trading under PEV symbol while they work to complete and file ...
$Cemtrex (CETX.US)$
Cemtrex Announces 1-For-35 Reverse Stock Split
Cemtrex announced a 1-for-35 reverse stock split of its common stock, effective November 26, 2024. The split aims to regain compliance with Nasdaq's minimum closing bid price requirement. Every 35 shares will combine into one share, with the stock continuing to trade under 'CETX'. No fractional shares will be issued, with holders receiving one whole share instead. The split will reduce outstanding shares to one-thirty-fifth ...
Cemtrex Announces 1-For-35 Reverse Stock Split
Cemtrex announced a 1-for-35 reverse stock split of its common stock, effective November 26, 2024. The split aims to regain compliance with Nasdaq's minimum closing bid price requirement. Every 35 shares will combine into one share, with the stock continuing to trade under 'CETX'. No fractional shares will be issued, with holders receiving one whole share instead. The split will reduce outstanding shares to one-thirty-fifth ...
$Alta Global Group (MMA.US)$
Alta Global Group Request for Withdrawal of Registration Statement on Form F-1
Alta Global Group Request for Withdrawal of Registration Statement on Form F-1
$Virpax Pharmaceuticals (VRPX.US)$
Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative
Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) ("Virpax" or the "Company"), a company specializing in developing pharmaceutical products for pain management, announced that it has been granted an extension of its cooperative research and development agreement with the National Ce...
Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative
Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) ("Virpax" or the "Company"), a company specializing in developing pharmaceutical products for pain management, announced that it has been granted an extension of its cooperative research and development agreement with the National Ce...
1